Roquette Reveals New Structure Post-IFF Pharma Acquisition
Company - People | May 05, 2025 | EIN
Roquette, a leader in plant-based ingredients and pharmaceutical excipients, has announced a revamped organizational structure following its acquisition of IFF Pharma Solutions. The reorganization includes the establishment of two strengthened Business Groups: Health & Pharma Solutions, led by Isabelle Bouvier, and Nutrition & Bioindustry, led by Pascal Leroy. This new structure is designed to enhance Roquette's agility and customer responsiveness, supporting sustainable long-term growth. With over 11,000 employees, 40 manufacturing sites, and a broad suite of global R&D and Innovation Centers, Roquette is positioned to expand its global presence and enhance its portfolio diversity across health, nutrition, and bio-industrial markets. Bouvier, previously Roquette's CFO, will also oversee the integration of Qualicaps, enhancing Roquette's leadership in pharmaceuticals. Meanwhile, Pascal Leroy will lead the company's nutrition and bioindustry sectors toward becoming a premier supplier of plant-based ingredients. Batrice Totel succeeds Bouvier as Roquette's CFO. The changes align with Roquette's commitment to innovation and providing sustainable solutions.
Sectors
- Pharmaceuticals
- Nutrition & Food Ingredients
- Agriculture & Plant-Based Ingredients
Geography
- Global – Roquette operates globally with a presence in over 150 countries, emphasizing its expanded global footprint after the acquisition.
- France – Roquette is headquartered in France, where significant organizational changes are being implemented.
Industry
- Pharmaceuticals – The acquisition involves IFF Pharma Solutions, part of the pharmaceutical excipients sector, which plays a crucial role in Roquette's new Health & Pharma Solutions Business Group.
- Nutrition & Food Ingredients – Roquette's Nutrition & Bioindustry Business Group focuses on sustainable ingredients, impacting the food and nutrition industry.
- Agriculture & Plant-Based Ingredients – Roquette specializes in plant-based ingredients, crucial for both its health and nutrition business sectors.
Financials
- 4.5 billion – Roquette's turnover in 2024, indicating its significant financial scale.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Roquette | Acquirer and Main Company | Company | A leader in plant-based ingredients and pharmaceutical excipients, enhancing global offerings post-acquisition. |
| IFF Pharma Solutions | Acquired Company | Company | Acquired by Roquette to strengthen its pharmaceutical and health sector capabilities. |
| Isabelle Bouvier | CEO of Health & Pharma Solutions Business Group | Person | Leads the newly formed business group, focused on enhancing Roquette's pharmaceutical segment. |
| Pascal Leroy | CEO of Nutrition & Bioindustry Business Group | Person | Oversees the nutrition business, focusing on sustainable growth through plant-based ingredients. |
| Batrice Totel | Chief Financial Officer (CFO) | Person | New CFO, continuing strategic financial leadership after Bouvier's transition. |
| Brunswick | PR Firm | Company | Handles Roquette's press and public relations communications. |